IL1B and nephritis: Direct evidence comes from LPS-enhanced heterologous anti-GBM nephritis in rats which were found to be partially protected by anti-IL-1β antibody treatment [27], but a contribution of NLRP3, ASC, and caspase-1 for intrinsic glomerular inflammation is still speculative.